Hsiao F-Y, Tsai Y-W, Huang W-F. Changes in physician’s practice of prescribing cyclooxy-genase-2 inhibitor after market withdrawal of rofecoxib: a ret-rospective study of physician-patient pairs in Taiwan. Clin Ther +2009; 31:2618-27.

has been cited by the following article: